Clinical Trials Logo
  1. Home
  2. Health Care Utilization
  3. NCT05367115

Verification of the Epidemiology and Mortality of Rare Diseases in Taiwan With Real-world Evidence

Health Care Utilization Clinical Trial

Official title:
National Cheng Kung University Hospital

Clinical Trial Summary

This study aims to explore the longitudinal incidence and prevalence trends of selected muscular and bone-related rare diseases, i.e., Familial Amyloidotic Polyneuropathy (FAP), Primary hyperoxaluria, Wilson's disease, Cystic fibrosis, Osteogenesis imperfecta, Porphyria, and Primary Paget disease, and analyze healthcare utilization.

Clinical Trial Description

A rare disease (RD) means any disease that affects a small percentage of the population. According to the "Rare Disease and Orphan Drug Act" in 2000, RD is defined as the prevalence of lower than 10,000 people in Taiwan, or with special circumstances, and announced after review by the "Review Committee for Rare Diseases and Orphan Drugs". There are many different causes of RD, such as genetic and infection. Although researchers have made progress in learning how to diagnose, treat, and even prevent a variety of RD, but there is still much to do because most rare diseases have no treatments. Due to the low morbidity rate and fewer numbers of people who suffer from RD, patients have been impacted by a severe pathology and insufficiently recognized, diagnosed, and cured. However, prevalence, healthcare utilization, and economic impacts of rare diseases based on real-world evidence are still unknown in the world, especially in Taiwan. In 2020, there were 226 diseases officially proclaimed as RD and 17,592 patients in Taiwan, and approved 108 orphan drugs and 40 special nutrients for treating those patients to reduce their financial burden. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05367115
Study type Observational
Source National Cheng-Kung University Hospital
Contact
Status Completed
Phase
Start date December 9, 2020
Completion date April 30, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05596474 - Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue N/A
Recruiting NCT05778578 - Universal Basic Income and Structural Racism in the US South N/A
Not yet recruiting NCT05558332 - Youth Nominated Support Team N/A
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Completed NCT05082935 - COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II N/A
Recruiting NCT05454969 - One-4-ALL Initiative N/A
Enrolling by invitation NCT05045222 - Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry
Completed NCT04587063 - Evaluation of Emails Promoting Mail-order Pharmacy N/A
Recruiting NCT05541913 - The Effect of Tele-Nursing on Parents of Circumcised Children N/A
Completed NCT05117333 - Reminders, Cost Sharing, and Healthcare Use N/A
Recruiting NCT04835012 - Health and Health Care Utilization Effects of Medical Debt Forgiveness
Completed NCT04567342 - Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination N/A
Withdrawn NCT05552638 - Telecare in Rural Senior Centers N/A
Enrolling by invitation NCT04250103 - Home-based Longitudinal Investigation of the Multidisciplinary Team Integrated Care
Completed NCT04240093 - CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder N/A
Active, not recruiting NCT03724695 - Advanced Heart Care at Home N/A
Completed NCT04517578 - European Neuromuscular Monitoring Survey
Active, not recruiting NCT05609188 - Black Economic Equity Movement N/A
Completed NCT04373135 - Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 N/A
Recruiting NCT05324566 - Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App